SUBSCRIBE
SUBSCRIBE

Phase I

Investors Sigh With Relief as Biogen's Alzheimer's Drug Delivers in Early-Stage Study
Drug Development
Investors Sigh With Relief as Biogen’s Alzheimer’s Drug Delivers in Early-Stage Study
December 9, 2016
 · 
2 min read
So Long 2016 (and Good Riddance?)
Drug Development
BioPharm Executive: So Long 2016 (and Good Riddance?)
December 7, 2016
 · 
8 min read
Investors Sigh With Relief as Biogen's Alzheimer's Drug Delivers in Early-Stage Study
Drug Development
All Eyes Will Be on Biogen and Its Much-Anticipated Alzheimer’s Data Tomorrow
December 7, 2016
 · 
2 min read
Top 5 Best U.S. Cities for Pharma and Biotech Scientist Jobs
Drug Development
4 Massachusetts Biotechs Making Waves at American Society of Hematology
December 6, 2016
 · 
2 min read
Antares Pharma Implodes After FDA Responds to Its Xyosted NDA
Drug Development
Top 7 Jaw-Dropping Pipeline Blowups This Year
December 5, 2016
 · 
4 min read
Kite Pharma's CAR-T Blood Cancer Candidate Succeeds in Major Study
Business
As Rival Juno Falters, Kite Pharma Touts New CAR-T Data and Maps Out BLA Submission Plans
December 5, 2016
 · 
2 min read
Proteostasis and Roche Diagnostics Ink Huge Space in New Boston Hub
Drug Development
bluebird bio, Celgene’s Multiple Myeloma CAR-T Drug Shines in Tiny Study
December 1, 2016
 · 
2 min read
Proteostasis and Roche Diagnostics Ink Huge Space in New Boston Hub
Drug Development
5 Drug Giants That Could Dominate the $13 Billion Alzheimer’s Market
November 22, 2016
 · 
3 min read
Celgene Cuddles Up With Another Cambridge Biotech, This Time to Tackle Autoimmune Diseases
Drug Development
The Franchise That Could Bring in Another $20 Billion for Celgene
November 22, 2016
 · 
2 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Drug Development
China Takes Lead in CRISPR Race, Will Test on a Human for the First Time
November 16, 2016
 · 
2 min read
Load More
PRESS RELEASES
Drug Development
Upstream Bio Presents New Phase 1 Clinical Data on UPB-101 at the American Thoracic Society (ATS) International Conference
May 22, 2023
 · 
4 min read
Drug Development
Keros Therapeutics Presents Preclinical and Clinical Data from its KER-012 Program at the American Thoracic Society International Conference
May 22, 2023
 · 
9 min read
Drug Development
Clearmind Medicine Announces First US Site for its Phase I/IIa Clinical Trial Evaluating CMND-100 in Patients with Alcohol Use Disorder
May 22, 2023
 · 
5 min read
Business
Panbela Announces Clinical Trial with Moffitt Cancer Center for Phase I/II Program in STK11 Mutant Non-Small Cell Lung Cancer
May 22, 2023
 · 
7 min read
Drug Development
BridgeBio Pharma Presents Updated Encouraging Clinical and Biomarker Data from its BBP-812 Canavan Disease Gene Therapy Program at the 2023 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
May 22, 2023
 · 
10 min read
Drug Development
IDEAYA Announces IND Clearance Enabling Phase 1/2 Clinical Trial for Combination of IDE397 and AMG 193 in MTAP-Deletion Solid Tumors
May 22, 2023
 · 
5 min read
Drug Development
AiViva Biopharma Initiates Phase 1 Clinical Trial of AIV007 for Age-Related Macular Degeneration and Diabetic Macular Edema
May 22, 2023
 · 
2 min read
Drug Development
Nexcella Announces Positive NXC-201 Clinical Results at ASGCT: 100% Overall Response Rate in DARZALEX-Relapsed/Refractory AL Amyloidosis with Zero ICANs in Ongoing NEXICART-1 Phase 1b/2a Clinical Trial
May 21, 2023
 · 
8 min read
Drug Development
Immix Biopharma Announces Positive NXC-201 Clinical Results at ASGCT: 100% Overall Response Rate in DARZALEX-Relapsed/Refractory AL Amyloidosis with Zero ICANs in Ongoing NEXICART-1 Phase 1b/2a Clinical Trial
May 21, 2023
 · 
9 min read
Drug Development
Neurimmune: Promising Phase 1 Results for Antibody NI006 in ATTR Cardiomyopathy Published in the New England Journal of Medicine
May 20, 2023
 · 
5 min read
Drug Development
Salubris Biotherapeutics Presents Positive Updates from Phase 1b Clinical Trial of JK07 in Late-Breaking Session at the European Society of Cardiology Heart Failure 2023 Congress
May 20, 2023
 · 
5 min read
Drug Development
Alpine Immune Sciences to Present Data from RUBY-1, a Phase 1 Study of Povetacicept, at Upcoming Scientific Congresses
May 19, 2023
 · 
5 min read
Drug Development
Celularity Announces Phase 1 Data Showing That MLASC Therapy in Patients With Crohn’s Disease May Be a Therapeutic Option to Manage Inflammatory Bowel Diseases and Prevent Fistula Formation
May 19, 2023
 · 
6 min read
Drug Development
Candel Therapeutics Announces New Data from Ongoing Phase 1 Clinical Trial of CAN-3110 in Recurrent High-Grade Glioma at the American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting
May 19, 2023
 · 
9 min read
Drug Development
Phase 1/2 Interim Data on Moderna’s mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia (PA), Presented at the 2023 ASGCT Annual Meeting
May 19, 2023
 · 
7 min read
Drug Development
Kymera Therapeutics Doses First Patient in Phase 1 Oncology Trial of MDM2 Degrader KT-253
May 19, 2023
 · 
6 min read
Drug Development
Cognition Therapeutics Publishes Clinical Evidence that CT1812 Displaces Aβ Oligomers from Binding to Neuronal Synapses in Alzheimer’s Disease- First Human Evidence that CT1812 Selectively Engages Aβ Oligomers
May 18, 2023
 · 
7 min read
Drug Development
AVROBIO Announces Positive Data from Phase 1/2 Clinical Trial of Investigational Gene Therapy for Cystinosis at the ASGCT 26th Annual Meeting
May 18, 2023
 · 
9 min read
Drug Development
Kymera Therapeutics Presents Clinical Data from the Phase 1 Trial of IRAK4 Degrader, KT-474 (SAR444656), at the European Academy of Dermatology and Venereology Symposium
May 18, 2023
 · 
7 min read
Drug Development
Antengene Announces Clearance of U.S. IND for the Phase I Trial of First-in-Class Anti-CD24 Monoclonal Antibody ATG-031
May 17, 2023
 · 
7 min read
Load More